Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1135)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$575.50
Total Value
$391.34K
Shares Held After
46,513
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$574.23
Total Value
$252.66K
Shares Held After
47,193
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$572.45
Total Value
$183.18K
Shares Held After
47,633
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
581
Price
$571.55
Total Value
$332.07K
Shares Held After
47,953
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,479
Price
$570.81
Total Value
$844.23K
Shares Held After
48,534
% of Holdings
3.0%
aTYR PHARMA INC (ATYR)
SCHIMMEL PAUL — Director
Shares
100,000
Price
$0.50
Total Value
$49.63K
Shares Held After
779,143
% of Holdings
12.8%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$77.21
Total Value
$579.08K
Shares Held After
392,830
% of Holdings
1.9%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
6,428
Price
$62.18
Total Value
$399.71K
Shares Held After
1,041,667
% of Holdings
0.6%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
19,679
Price
$31.47
Total Value
$619.37K
Shares Held After
25,249
% of Holdings
43.8%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
600
Price
$82.08
Total Value
$49.25K
Shares Held After
44,018
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
3,679
Price
$81.50
Total Value
$299.85K
Shares Held After
44,618
% of Holdings
7.6%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Faisal Ghiath — Director
Shares
122,174
Price
$0.41
Total Value
$50.01K
Shares Held After
125,574
% of Holdings
97.3%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
23,190
Price
$1.06
Total Value
$24.47K
Shares Held After
58,014
% of Holdings
40.0%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
11,798
Price
$30.06
Total Value
$354.66K
Shares Held After
793
% of Holdings
93.7%
EXELIXIS, INC. (EXEL)
Aftab Dana — EVP, Research and Development
Shares
43,451
Price
$50.35
Total Value
$2.19M
Shares Held After
594,741
% of Holdings
6.8%
OCULAR THERAPEUTIX, INC (OCUL)
Nayak Sanjay — Chief Strategy Officer
Shares
1,858
Price
$8.20
Total Value
$15.24K
Shares Held After
328,795
% of Holdings
0.6%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
64,399
Price
$53.98
Total Value
$3.48M
Shares Held After
0
% of Holdings
100.0%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
421
Price
$154.82
Total Value
$65.18K
Shares Held After
54,400
% of Holdings
0.8%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
2,000
Price
$154.06
Total Value
$308.12K
Shares Held After
54,821
% of Holdings
3.5%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
700
Price
$153.30
Total Value
$107.31K
Shares Held After
56,821
% of Holdings
1.2%
RIGEL PHARMACEUTICALS INC (RIGL)
Ali-Jackson Kamil — Director
Shares
2,500
Price
$29.17
Total Value
$72.92K
Shares Held After
12,625
% of Holdings
16.5%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,000
Price
$18.21
Total Value
$36.42K
Shares Held After
20,000
% of Holdings
10.0%
INCYTE CORP (INCY)
Tray Thomas — Principal Accounting Officer
Shares
2,051
Price
$97.35
Total Value
$199.66K
Shares Held After
21,132
% of Holdings
8.8%
OCULAR THERAPEUTIX, INC (OCUL)
Kaiser Peter — Chief Development Officer
Shares
2,967
Price
$8.20
Total Value
$24.33K
Shares Held After
266,141
% of Holdings
1.1%
OCULAR THERAPEUTIX, INC (OCUL)
Dugel Pravin — Director
Shares
21,156
Price
$8.20
Total Value
$173.48K
Shares Held After
2,597,170
% of Holdings
0.8%
OCULAR THERAPEUTIX, INC (OCUL)
Heier Jeffrey S. — Chief Scientific Officer
Shares
3,018
Price
$8.20
Total Value
$24.75K
Shares Held After
320,350
% of Holdings
0.9%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
18,572
Price
$40.05
Total Value
$743.75K
Shares Held After
6,280,525
% of Holdings
0.3%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
568
Price
$3.10
Total Value
$1.76K
Shares Held After
0
% of Holdings
100.0%
Ainos, Inc. (AIMD)
lee ting-chuan — Director
Shares
109,988
Price
$1.90
Total Value
$208.98K
Shares Held After
807,417
% of Holdings
12.0%
Ainos, Inc. (AIMD)
TSAI CHUN-JUNG — Director
Shares
27,718
Price
$1.87
Total Value
$51.83K
Shares Held After
658,199
% of Holdings
4.0%
Ainos, Inc. (AIMD)
Taiwan Carbon Nano Technology Corp — 10% Owner
Shares
41,000
Price
$2.36
Total Value
$96.76K
Shares Held After
948,925
% of Holdings
4.1%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
37,524
Price
$31.49
Total Value
$1.18M
Shares Held After
25,249
% of Holdings
59.8%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
5,401
Price
$21.18
Total Value
$114.39K
Shares Held After
24,509
% of Holdings
18.1%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
551
Price
$80.71
Total Value
$44.47K
Shares Held After
48,297
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
4,500
Price
$80.02
Total Value
$360.11K
Shares Held After
48,848
% of Holdings
8.4%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
3,800
Price
$79.39
Total Value
$301.69K
Shares Held After
53,348
% of Holdings
6.6%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
324
Price
$79.17
Total Value
$25.65K
Shares Held After
57,148
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
3,730
Price
$78.36
Total Value
$292.27K
Shares Held After
57,472
% of Holdings
6.1%
Krystal Biotech, Inc. (KRYS)
Thomas John Charles — EVP, General Counsel
Shares
642
Price
$302.03
Total Value
$193.90K
Shares Held After
0
% of Holdings
100.0%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
4,000
Price
$6.10
Total Value
$24.40K
Shares Held After
700,000
% of Holdings
0.6%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$239.37
Total Value
$47.87K
Shares Held After
400
% of Holdings
50.0%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
1,966
Price
$26.78
Total Value
$52.65K
Shares Held After
229,918
% of Holdings
0.8%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$236.24
Total Value
$47.25K
Shares Held After
200
% of Holdings
100.0%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
2,239
Price
$26.78
Total Value
$59.96K
Shares Held After
150,260
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
760
Price
$578.12
Total Value
$439.37K
Shares Held After
18,876
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,929
Price
$577.13
Total Value
$1.11M
Shares Held After
19,636
% of Holdings
8.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,221
Price
$576.21
Total Value
$703.55K
Shares Held After
21,565
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
809
Price
$575.24
Total Value
$465.37K
Shares Held After
22,786
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
281
Price
$574.13
Total Value
$161.33K
Shares Held After
23,595
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$572.70
Total Value
$251.99K
Shares Held After
23,876
% of Holdings
1.8%
Showing 51–100 of 1135 transactions (page 2 of 23)